aagami consutling
DESCRIPTION
Aagami offers its consulting services to Pharma, Biotech, Medical Devices and Infotech companies for theur India initiativesTRANSCRIPT
May 2010Confidential © Aagami Inc. -
Aagami, Inc.
Strategic Consulting Services
LifeSciences Catalyst
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Aagami, Inc.
A life sciences services company based in suburbs
of Chicago, offers
Strategic Consulting Services
Drug Development Services Phase I to Phase IV clinical studies
BA, BE and PK/PD studies
Technology Licensing Services
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Strategic Consulting Services
Investments to and from India
In-Licensing or Out-Licensing
Mergers & Acquisitions targets
Finding the Right
JV partners and/or Distributors
CRO and CRAMS providers
Contract Sales/Marketing companies
Contract Manufacturing companies
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Needs of Mid and Small US firms
Investments for product development
Partnerships for co-development and
marketing
Cost effective Service providers for
product Development and Manufacturing
Contract Sales and Marketing companies
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Indian Industry Snapshot
4th Largest Pharma market (by volume)
Top 100 companies are present in 50+ countries
Top 20 have presence in Regulated markets
Globally successful in Generics
Looking to differentiate generic portfolio
Developing Innovative products portfolio
Increasingly seeking global market share
Therefore, hungry to acquire companies and
technologies globally, especially in regulated
markets
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Indian Firms are targeting
Acquisitions for
Innovative compounds and technologies
Companies in Regulated markets
Novel Drug Delivery Systems
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Indian Service Providers bring
Quality Services for FDA Approvals:GCP, GLP & GMP (as per US-FDA standards)
Largest # USFDA Approved GMP facilities
Highest # of DMF filings
Speedier Development Processes:
Large number of Experienced Scientists
Well established and mature Industry
Cost Effective Solutions:
PPP with US is 1:5 – As per World Bank
Easy availability of skilled human resources
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Aagami brings
Extensive Experience in the US Biotech,
Pharmaceutical and Medical Device industry
Understanding of ways of working (business
culture) & Deal experience with Indian industry
Extensive network with top 100 Indian LS
companies at CXO levels
Global Licensing and Investing Experience
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Sample list of assignments Finding partner to manufacture Peptides for a EU conglomerate
In-Licensing Oncology and Immunology NCEs for the pioneer of Biotech
Out-Licensing and Investing in a Intranasal Drug Delivery Device company from West coast of US
Licensing Bioavailability enhancers for a CA company
Strategic Investment in or Licensing the Oral Controlled Release technology of a CT company
Strategic Investments in an Ophthalmic Medical Device of a Mid-West company; Term sheet signed
Licensing for a new dermatology delivery system, applicable to both pharmaceutical and personal care products.
Licensing and Investment for a Southern US company with GI safe NSAIDs
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Sample List of Clients
Solvay Organics
Penwest Pharmaceuticals
Aegis Therapeutics
ScyFIX
Agile Therapeutics
Kurve Technologies
The pioneer of Biotech
Phosphagenics
PLx Pharma
May 2010Confidential © Aagami Inc. -
Dedicated promotion
Small retainer fee
Success fee based on the Lehman’s
How we do it
Confidential © Aagami Inc.- May 2010Life Sciences Catalyst
Key people
Dinesh JainA business leader in Science and technology industry for over 26 years with global experience in starting and managing several technology companies. Has held positions of CEO, President, Vice President. Is a prolific entrepreneur, Board member and speaker at international business conferences. Has executed several dozen international deals in 3 continents.
Mahendra ShahA veteran Scientific leader of 41 years in Bio-Pharmaceutical field. After his PhD, he has worked with some of the top notch companies like Bristol, Squibb, Schering, Lyphomed, Fujisawa. Mahendra has been an active Investor in BioPharmaceutical field and is on the Board of several companies across the country. At present he is CEO of Next Wave Pharmaceuticals.
Shridhar AndurkarChair and Associate Professor of Pharmaceutical sciences at Midwestern University, Chicago College of Pharmacy, is a Ph D from Auburn University in Medicinal Chemistry, Conducted postdoctoral research at the University of Houston. Dr. Andurkar has published numerous papers and made several presentations in this field. He holds a US patent in the area of anticonvulsant drugs. Is on the advisory boards of several companies.
May 2010Confidential © Aagami Inc. -
Aagami, Inc.
2020 Calamos Ct, Suite 209
Naperville, IL 60564
Phone: (630) 799-1572
www.aagami.net
Enabling Strategic Partnerships